Healthcare News and Research

Latest Healthcare News and Research

QuantuMDx receives CE-IVD marking for SARS-CoV-2 detection assay

QuantuMDx Group Limited, a UK-based life sciences company developing transformational point-of-care molecular diagnostics, today announces its SARS-CoV-2 detection assay has been CE-IVD marked under the In Vitro Diagnostics Directive (98/79/EC), enabling use within the European Union.

10 Jun 2020

Unique partnership aims to accelerate the adoption of AI in healthcare

The Michener Institute of Education at UHN and Vector Institute are setting out to transform the skills and capabilities of front-line healthcare professionals in the application of artificial intelligence to health services.

10 Jun 2020

Gilead and Kite to present data from cell therapy research at 25th EHA Virtual Congress

Gilead Sciences, Inc. and Kite, a Gilead Company, are pleased to support the Virtual Edition of the 25th European Hematology Association Annual Congress, taking place 11–21 June 2020.

From Gilead Sciences, Inc. 10 Jun 2020

EKF opens for live chats at ENDO Online 2020

EKF Diagnostics, the global in vitro diagnostics company, announces that its online exhibition booth at this year’s ENDO Online 2020 is open for live chats on its range of diagnostics products for glycemic monitoring and ketosis testing from 10 - 17th June.

From EKF Diagnostics 10 Jun 2020

Role of nuclear cardiology in COVID-19

"We know that without a vaccine we're going to be dealing with this virus for a while," said Johnese Spisso, president of UCLA Health, in an interview with Johannes Czernin.

10 Jun 2020

Study: Breast cancer reduction efforts show mixed progress

The data is clear: for patients with early stage breast cancer, certain operations risk more harm than good - increasing the risk of medical complications, missed work and health care costs without increasing survival rates.

10 Jun 2020

COVID-19 lockdowns estimated to have prevented 3 million deaths across 11 European countries

Now, a new study by researchers at Imperial College London estimates that lockdowns prevented around 3.1 million deaths in 11 European countries. The modeling study, published in the journal Nature, highlights that social distancing measures worked in reducing the spread of the virus.

10 Jun 2020

Deep UV LED inactivation of SARS-CoV-2 - fast and effective

The ongoing pandemic has aroused considerable effort to find methods to prevent and control the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19 disease. Rapid inactivation devices would be of great help in this area, to prevent viral transmission through aerosols and contact with infected surfaces.

9 Jun 2020

"A shred of evidence" BCG vaccinations protect against COVID-19

Professor David Levine from the University of California, Berkeley, says a study of people in Spain and Italy has provided a “shred of evidence” that the BCG vaccination may protect against coronavirus disease 2019 (COVID-19).

9 Jun 2020

Study estimates health and economic impacts of the national menu calorie labeling law

The national law requiring chain restaurants to include calorie labels on menus is estimated to prevent tens of thousands of new heart disease and type 2 diabetes cases--and save thousands of lives--in just five years, according to a new study estimating the law's impact.

9 Jun 2020

New Finnish study explores the economic burden of alcohol use disorders

Alcohol use disorders are associated with high social welfare and health care costs - but what causes them? A new Finnish study looks at the magnitude and reasons behind the economic burden alcohol use disorders have on society.

9 Jun 2020

Santen Pharmaceutical and jCyte conclude an exclusive licensing contract in Japan, Asia and Europe for the jCell therapy programme for retinitis pigmentosa

Santen Pharmaceutical Co., Ltd. and jCyte Inc. announced the conclusion of an exclusive licensing contract covering the development, registration and commercialisation rights in Japan, Asia and Europe to jCell, a first-in-class investigational therapy, currently in clinical development for retinitis pigmentosa.

From Santen Pharmaceutical Co., Ltd. 9 Jun 2020

Anti-RBD antibodies shown to neutralize active SARS-CoV-2

A new study published on the preprint server bioRxiv* in June 2020 reports the discovery of multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in samples from healthy donors, collected before the pandemic. These antibodies are capable of inhibiting the binding of the spike protein of the virus to the angiotensin-converting enzyme 2 (ACE2) molecule and can neutralize active infection of cells in culture.

9 Jun 2020

Metabolic diseases alter ACE2 expression and increase COVID-19 severity

A new study published on the preprint server medRxiv in June 2020 reports that one mechanism for this variable severity is the differential expression of the ACE2 receptor in various metabolic conditions, thereby facilitating viral entry into the host cells.

9 Jun 2020

Cremation numbers reveal possible suppression of true COVID-19 data in China

A potentially explosive new study published on the preprint server medRxiv in June 2020 suggests that the official Chinese statistics on COVID-19 cases or mortality are neither reliable nor credible. If true, such unreliable data during a crucial period of the pandemic in February and March 2020 could have seriously skewed the response and preparation of the rest of the world and altered the future course of the viral pneumonic illness.

8 Jun 2020

Scientists harness cancer immunotherapy tools to identify targets for COVID-19 vaccine

Cancer researchers at Children's Hospital of Philadelphia have harnessed tools used for the development of cancer immunotherapies and adapted them to identify regions of the SARS-CoV-2 virus to target with a vaccine, employing the same approach used to elicit an immune response against cancer cells to stimulate an immune response against the virus.

8 Jun 2020

New syndrome associated with SARS-CoV-2 is new and distinct from Kawasaki disease

A study on children suffering from severe inflammatory symptoms shows the condition is new and distinct from Kawasaki disease.

8 Jun 2020

Human movement, poverty influence COVID-19 measures

A new study published on the preprint server medRxiv* in June 2020 explains the significant risk posed by poverty and the success of measures to counter COVID-19. The research sets out a model for more focused but productive interventions in high-risk groups that can reduce mortality rates significantly.

8 Jun 2020

Innovative effort solves health system's shortage of nasopharyngeal swabs

An innovative effort launched in April and led by a fellow in the UCLA Biodesign program has yielded positive results, solving the health system's shortage of nasopharyngeal swabs - a key element in COVID-19 testing - at a time when Southern California is seeing a rise in new cases and new deaths per day.

8 Jun 2020

Mount Sinai receives award from Microsoft AI for Health to support COVID Informatics Center

The Mount Sinai Health System has received an award from Microsoft AI for Health to support the work of a new data science center dedicated to COVID-19 research.

8 Jun 2020

Healthcare News and Research

Latest Healthcare News and Research

QuantuMDx receives CE-IVD marking for SARS-CoV-2 detection assay

Unique partnership aims to accelerate the adoption of AI in healthcare

Gilead and Kite to present data from cell therapy research at 25th EHA Virtual Congress

EKF opens for live chats at ENDO Online 2020

Role of nuclear cardiology in COVID-19

Study: Breast cancer reduction efforts show mixed progress

COVID-19 lockdowns estimated to have prevented 3 million deaths across 11 European countries

Deep UV LED inactivation of SARS-CoV-2 - fast and effective

"A shred of evidence" BCG vaccinations protect against COVID-19

Study estimates health and economic impacts of the national menu calorie labeling law

New Finnish study explores the economic burden of alcohol use disorders

Santen Pharmaceutical and jCyte conclude an exclusive licensing contract in Japan, Asia and Europe for the jCell therapy programme for retinitis pigmentosa

Anti-RBD antibodies shown to neutralize active SARS-CoV-2

Metabolic diseases alter ACE2 expression and increase COVID-19 severity

Cremation numbers reveal possible suppression of true COVID-19 data in China

Scientists harness cancer immunotherapy tools to identify targets for COVID-19 vaccine

New syndrome associated with SARS-CoV-2 is new and distinct from Kawasaki disease

Human movement, poverty influence COVID-19 measures

Innovative effort solves health system's shortage of nasopharyngeal swabs

Mount Sinai receives award from Microsoft AI for Health to support COVID Informatics Center

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Healthcare News and Research

Latest Healthcare News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in